Last checked at 13 Sep 2018 07:00
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
Surgical Innovations Group plc
("SI Group" or the "Company")
CE mark certification obtained for CELLIS range
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical technology for minimally invasive surgery, provides a further update relating to the CELLIS range of products supplied to its UK distribution business, Elemental Healthcare Limited ("Elemental") by Meccellis Biotech SA ("Meccellis").
On 12 September 2018, Elemental received confirmation from Meccellis that CE certification has been issued in respect of the full range of CELLIS products previously sold by Elemental, and also covering innovative new products including the CELLIS Breast Pocket range launched at the London Breast meeting on 6 & 7 September 2018. The certificates are valid until August 2023.
Meccellis are now in a position to resume manufacture of these products, and detailed plans are in progress to facilitate a timely and controlled reintroduction to the UK market in coming weeks.
For further information please contact:
Surgical Innovations Group Plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 |
Melanie Ross, COO and CFO |
|
|
|
WH Ireland Limited (NOMAD & Broker) | Tel: 0113 394 6600 |
Tim Feather |
|
Chris Viggor |
|
|
|
Walbrook PR (Financial PR & Investor Relations) | Tel: 020 7933 8780 or si@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |